Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

G. Caocci, O. Mulas, E. Abruzzese, L. Luciano, A. Iurlo, I. Attolico, F. Castagnetti, S. Galimberti, N. Sgherza, M. Bonifacio, M. Annunziata, A. Gozzini, E.M. Orlandi, F. Stagno, G. Binotto, P. Pregno, C. Fozza, M.M. Trawinska, F. De Gregorio, D. CattaneoF. Albano, G. Gugliotta, C. Baratè, L. Scaffidi, C. Elena, F. Pirillo, E. Scalzulli, G. La Nasa, R. Foà, M. Breccia

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)296-302
Number of pages7
JournalHematological Oncology
Volume37
Issue number3
DOIs
Publication statusPublished - 2019

Keywords

  • arterial occlusive event
  • chronic myeloid leukemia
  • ponatinib
  • prophylaxis
  • acetylsalicylic acid
  • imidazole derivative
  • pyridazine derivative
  • adult
  • aged
  • cardiology
  • clinical decision support system
  • clinical trial
  • complication
  • coronary artery occlusion
  • epidemiology
  • female
  • human
  • hypertension
  • incidence
  • Italy
  • male
  • middle aged
  • multicenter study
  • oncology
  • procedures
  • retrospective study
  • risk factor
  • treatment outcome
  • very elderly
  • young adult
  • Adult
  • Aged
  • Aged, 80 and over
  • Aspirin
  • Cardiology
  • Coronary Occlusion
  • Decision Support Systems, Clinical
  • Female
  • Humans
  • Hypertension
  • Imidazoles
  • Incidence
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Male
  • Medical Oncology
  • Middle Aged
  • Pyridazines
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Young Adult

Cite this

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. / Caocci, G.; Mulas, O.; Abruzzese, E.; Luciano, L.; Iurlo, A.; Attolico, I.; Castagnetti, F.; Galimberti, S.; Sgherza, N.; Bonifacio, M.; Annunziata, M.; Gozzini, A.; Orlandi, E.M.; Stagno, F.; Binotto, G.; Pregno, P.; Fozza, C.; Trawinska, M.M.; De Gregorio, F.; Cattaneo, D.; Albano, F.; Gugliotta, G.; Baratè, C.; Scaffidi, L.; Elena, C.; Pirillo, F.; Scalzulli, E.; La Nasa, G.; Foà, R.; Breccia, M.

In: Hematological Oncology, Vol. 37, No. 3, 2019, p. 296-302.

Research output: Contribution to journalArticle

Caocci, G, Mulas, O, Abruzzese, E, Luciano, L, Iurlo, A, Attolico, I, Castagnetti, F, Galimberti, S, Sgherza, N, Bonifacio, M, Annunziata, M, Gozzini, A, Orlandi, EM, Stagno, F, Binotto, G, Pregno, P, Fozza, C, Trawinska, MM, De Gregorio, F, Cattaneo, D, Albano, F, Gugliotta, G, Baratè, C, Scaffidi, L, Elena, C, Pirillo, F, Scalzulli, E, La Nasa, G, Foà, R & Breccia, M 2019, 'Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart', Hematological Oncology, vol. 37, no. 3, pp. 296-302. https://doi.org/10.1002/hon.2606
Caocci, G. ; Mulas, O. ; Abruzzese, E. ; Luciano, L. ; Iurlo, A. ; Attolico, I. ; Castagnetti, F. ; Galimberti, S. ; Sgherza, N. ; Bonifacio, M. ; Annunziata, M. ; Gozzini, A. ; Orlandi, E.M. ; Stagno, F. ; Binotto, G. ; Pregno, P. ; Fozza, C. ; Trawinska, M.M. ; De Gregorio, F. ; Cattaneo, D. ; Albano, F. ; Gugliotta, G. ; Baratè, C. ; Scaffidi, L. ; Elena, C. ; Pirillo, F. ; Scalzulli, E. ; La Nasa, G. ; Foà, R. ; Breccia, M. / Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. In: Hematological Oncology. 2019 ; Vol. 37, No. 3. pp. 296-302.
@article{bea912b3d43549bca6e1e362815e1957,
title = "Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart",
keywords = "arterial occlusive event, chronic myeloid leukemia, ponatinib, prophylaxis, acetylsalicylic acid, imidazole derivative, pyridazine derivative, adult, aged, cardiology, clinical decision support system, clinical trial, complication, coronary artery occlusion, epidemiology, female, human, hypertension, incidence, Italy, male, middle aged, multicenter study, oncology, procedures, retrospective study, risk factor, treatment outcome, very elderly, young adult, Adult, Aged, Aged, 80 and over, Aspirin, Cardiology, Coronary Occlusion, Decision Support Systems, Clinical, Female, Humans, Hypertension, Imidazoles, Incidence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Medical Oncology, Middle Aged, Pyridazines, Retrospective Studies, Risk Factors, Treatment Outcome, Young Adult",
author = "G. Caocci and O. Mulas and E. Abruzzese and L. Luciano and A. Iurlo and I. Attolico and F. Castagnetti and S. Galimberti and N. Sgherza and M. Bonifacio and M. Annunziata and A. Gozzini and E.M. Orlandi and F. Stagno and G. Binotto and P. Pregno and C. Fozza and M.M. Trawinska and {De Gregorio}, F. and D. Cattaneo and F. Albano and G. Gugliotta and C. Barat{\`e} and L. Scaffidi and C. Elena and F. Pirillo and E. Scalzulli and {La Nasa}, G. and R. Fo{\`a} and M. Breccia",
note = "Export Date: 24 September 2019 CODEN: HAOND Correspondence Address: Caocci, G.; Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of CagliariItaly; email: giovanni.caocci@unica.it",
year = "2019",
doi = "10.1002/hon.2606",
language = "English",
volume = "37",
pages = "296--302",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

AU - Caocci, G.

AU - Mulas, O.

AU - Abruzzese, E.

AU - Luciano, L.

AU - Iurlo, A.

AU - Attolico, I.

AU - Castagnetti, F.

AU - Galimberti, S.

AU - Sgherza, N.

AU - Bonifacio, M.

AU - Annunziata, M.

AU - Gozzini, A.

AU - Orlandi, E.M.

AU - Stagno, F.

AU - Binotto, G.

AU - Pregno, P.

AU - Fozza, C.

AU - Trawinska, M.M.

AU - De Gregorio, F.

AU - Cattaneo, D.

AU - Albano, F.

AU - Gugliotta, G.

AU - Baratè, C.

AU - Scaffidi, L.

AU - Elena, C.

AU - Pirillo, F.

AU - Scalzulli, E.

AU - La Nasa, G.

AU - Foà, R.

AU - Breccia, M.

N1 - Export Date: 24 September 2019 CODEN: HAOND Correspondence Address: Caocci, G.; Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of CagliariItaly; email: giovanni.caocci@unica.it

PY - 2019

Y1 - 2019

KW - arterial occlusive event

KW - chronic myeloid leukemia

KW - ponatinib

KW - prophylaxis

KW - acetylsalicylic acid

KW - imidazole derivative

KW - pyridazine derivative

KW - adult

KW - aged

KW - cardiology

KW - clinical decision support system

KW - clinical trial

KW - complication

KW - coronary artery occlusion

KW - epidemiology

KW - female

KW - human

KW - hypertension

KW - incidence

KW - Italy

KW - male

KW - middle aged

KW - multicenter study

KW - oncology

KW - procedures

KW - retrospective study

KW - risk factor

KW - treatment outcome

KW - very elderly

KW - young adult

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Aspirin

KW - Cardiology

KW - Coronary Occlusion

KW - Decision Support Systems, Clinical

KW - Female

KW - Humans

KW - Hypertension

KW - Imidazoles

KW - Incidence

KW - Leukemia, Myelogenous, Chronic, BCR-ABL Positive

KW - Male

KW - Medical Oncology

KW - Middle Aged

KW - Pyridazines

KW - Retrospective Studies

KW - Risk Factors

KW - Treatment Outcome

KW - Young Adult

U2 - 10.1002/hon.2606

DO - 10.1002/hon.2606

M3 - Article

VL - 37

SP - 296

EP - 302

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 3

ER -